0001873062-23-000001.txt : 20230512
0001873062-23-000001.hdr.sgml : 20230512
20230512093554
ACCESSION NUMBER: 0001873062-23-000001
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20230512
DATE AS OF CHANGE: 20230512
EFFECTIVENESS DATE: 20230512
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Comanche Biopharma Corp.
CENTRAL INDEX KEY: 0001873062
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-481558
FILM NUMBER: 23913576
BUSINESS ADDRESS:
STREET 1: 18 MAIN STREET
CITY: CONCORD
STATE: MA
ZIP: 01742
BUSINESS PHONE: 000-000-0000
MAIL ADDRESS:
STREET 1: 18 MAIN STREET
CITY: CONCORD
STATE: MA
ZIP: 01742
D
1
primary_doc.xml
X0708
D
LIVE
0001873062
Comanche Biopharma Corp.
50 Beharrell Street
#50-B
Concord
MA
MASSACHUSETTS
01742
617-206-3776
DELAWARE
Comanche Corp.
None
Corporation
true
2020
Thomas
Scott
Johnson
50 Beharrell Street
#50-B
Concord
MA
MASSACHUSETTS
01742
Executive Officer
Director
Ketan
Patel
50 Beharrell Street
#50-B
Concord
MA
MASSACHUSETTS
01742
Director
Brendan
Bulik-Sullivan
50 Beharrell Street
#50-B
Concord
MA
MASSACHUSETTS
01742
Director
Muzammil
Mansuri
50 Beharrell Street
#50-B
Concord
MA
MASSACHUSETTS
01742
Director
Clive
Meanwell
50 Beharrell Street
#50-B
Concord
MA
MASSACHUSETTS
01742
Director
Arthur
Levin
50 Beharrell Street
#50-B
Concord
MA
MASSACHUSETTS
01742
Director
Michael
Young
50 Beharrell Street
#50-B
Concord
MA
MASSACHUSETTS
01742
Executive Officer
Paul
Antinori
50 Beharrell Street
#50-B
Concord
MA
MASSACHUSETTS
01742
Executive Officer
Ann
Taylor
50 Beharrell Street
#50-B
Concord
MA
MASSACHUSETTS
01742
Director
Allyson
Felix
50 Beharrell Street
#50-B
Concord
MA
MASSACHUSETTS
01742
Director
Allison
August
50 Beharrell Street
#50-B
Concord
MA
MASSACHUSETTS
01742
Executive Officer
Pharmaceuticals
Decline to Disclose
- 06b
false
2021-06-28
true
true
false
0
36100007
36100007
0
false
7
0
0
0
false
Comanche Biopharma Corp.
/s/ T. Scott Johnson
T. Scott Johnson
Chief Executive Officer
2023-05-12